Education Blog for Healthcare Professionals

Heavier Menstrual Bleeding on Xarelto?

Stephan Moll, MD writes… Interesting and noteworthy observations published in the last 2 weeks:  Heavy menstrual bleeding appears to occur more commonly with Xarelto® than with warfarin [ref 1] and may be also more common with Xarelto® than with Eliquis® [ref 2].

Publication #1 [ref 1]:  A sub-analysis of the EINSTEIN-DVT and EINSTEIN-PE rivaroxaban versus warfarin studies showed that abnormal uterine bleeding  occurred more commonly in women on Xarelto® than in women on warfarin (30.7 %/year versus 13.4 %/year) and also more commonly led to blood transfusions (4.8 %/year versus 0. 5%/year).

Publication #2 [ref 2]:  A real-world prospective observational study of 96 women on Xarelto® and 43 women on Eliquis®showed that heavy menstrual bleeding occurred in 25 % of women on Xarelto® and in 9.3 % of women on Eliquis®.  The study design and the small number of women studied, particularly in the Eliquis® group, have, of course, significant limitations, but the observation is, nevertheless, interesting.

It needs to be determined with follow-up studies (a) whether these findings hold true, and (b) whether the increased bleeding risk is an individual drug effect of Xarelto® or a class effect of all new (direct) oral anticoagulants (i.e. Xarelto®, Eliquis®, Pradaxa®, and Savaysa®).

 

References:

  1. Martinelli I et al. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use. Blood 2016;17:1417-25.
  2. Myers B et al. Heavy menstrual bleeding on rivaroxaban – comparison with apixaban. Br J Haematol 2016;doi:10.1111/bjh.14003 [Epub ahead of print].

 

Conflict of interest: none

Last updated: March 30th, 2016

Tags: , , , , , ,

This entry was posted by Clot Connect on at and is filed under Bleeding, Uncategorized, Women and blood clots. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.